The CLINUVEL story starts in 1987 when university researchers launched an idea of synthesising human hormones to protect the skin. During this period, little was known about the properties of alpha-MSH (melanocyte stimulating hormone), although the scientists had discovered the biomimicry which these hormones could evoke (providing a golden glow without sun exposure). A basis […]
The CLINUVEL Group focusses its research and development on the interaction of skin with its environments aiming to deliver innovative medical solutions for complex problems.
The CLINUVEL Group works to translate scientific breakthroughs into commercial products. We are relentless in our desire to excel scientific research and development, building on our global expertise to deliver lifelong care and novel products for patients and consumers.
The CLINUVEL Group pledges to adhere to a principal set of values, which reflect how we operate and expand our business. These fall into five main categories; Technology, Approach, People and Environment, Knowledge Building and Sharing and Respect and Appreciation. The CLINUVEL Group values its People and Environment as central to all of the Group’s […]
As can be gleaned from ‘Understanding CLINUVEL’ we place much emphasis on users’ abilities and eagerness to learn more about our products and services. In the 21st century, CLINUVEL companies are in continuous dialogue with patients, consumers and all other interested parties, since information is key and distinguishes successful companies from each other. Differing from […]
The CLINUVEL Board is committed to good corporate governance. CLINUVEL’s corporate governance policies are available for review and download via the links below. Date Title Download February 2017 Corporate Governance Protocol July 2019 Board Charter July 2019 Remuneration Committee Charter July 2019 Audit & Risk Committee Charter October 2020 Diversity Policy July 2019 Nomination Committee […]